Fidelity Investments’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.85M Buy
71,720
+4,651
+7% +$424K ﹤0.01% 2291
2026
Q1
$6.46M Buy
67,069
+337
+0.5% +$33.7K ﹤0.01% 2217
2025
Q4
$6.49M Buy
66,732
+46,274
+226% +$3.97M ﹤0.01% 2195
2025
Q3
$1.46M Buy
20,458
+19,642
+2,407% +$1.31M ﹤0.01% 2660
2025
Q2
$48.8K Buy
816
+148
+22% +$8.11K ﹤0.01% 3921
2025
Q1
$35K Sell
668
-60
-8% -$3.37K ﹤0.01% 4008
2024
Q4
$40K Buy
728
+57
+8% +$3K ﹤0.01% 3949
2024
Q3
$33.8K Buy
671
+46
+7% +$2.12K ﹤0.01% 3950
2024
Q2
$27.5K Buy
625
+254
+68% +$10.8K ﹤0.01% 3920
2024
Q1
$16.3K Sell
371
-8,191
-96% -$362K ﹤0.01% 4095
2023
Q4
$406K Sell
8,562
-715
-8% -$30.1K ﹤0.01% 2740
2023
Q3
$412K Buy
9,277
+385
+4% +$17.9K ﹤0.01% 2676
2023
Q2
$425K Buy
8,892
+12
+0.1% +$541 ﹤0.01% 2709
2023
Q1
$349K Buy
8,880
+154
+2% +$5.6K ﹤0.01% 2811
2022
Q4
$247K Buy
8,726
+103
+1% +$2.95K ﹤0.01% 2947
2022
Q3
$259K Sell
8,623
-22
-0.3% -$766 ﹤0.01% 2978
2022
Q2
$293K Sell
8,645
-139
-2% -$4.98K ﹤0.01% 3023
2022
Q1
$394K Buy
+8,784
New +$406K ﹤0.01% 3058

Other funds holding IRMD

Fidelity Investments's IRMD Position: Q2 2026 in Review

Fidelity Investments increased its iRadimed (IRMD) stake by 6.9% in Q2 2026, buying an estimated $424K and bringing the position to 71,720 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

Fidelity Investments first reported a position in IRMD in Q1 2022 and has held it in 18 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Fidelity Investments held 71,720 shares of iRadimed worth $6.85M as of Q2 2026.
  • Fidelity Investments bought 4,651 iRadimed shares in Q2 2026, an estimated $424K.
  • iRadimed made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2291 holding.
  • Fidelity Investments first reported a position in iRadimed in Q1 2022 and has held it in 18 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.